Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stearns, V.
Right arrow Articles by Tsangaris, T. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stearns, V.
Right arrow Articles by Tsangaris, T. N.
Related Collections
Right arrow Sentinel lymph node
Annals of Surgical Oncology 9:235-242 (2002)
© 2002 Society of Surgical Oncology

ORIGINAL ARTICLES

Sentinel Lymphadenectomy After Neoadjuvant Chemotherapy for Breast Cancer May Reliably Represent the Axilla Except for Inflammatory Breast Cancer

Vered Stearns, MD, C. Alexander Ewing, MD, Rebecca Slack, MS, Marie F. Penannen, MD, Daniel F. Hayes, MD and Theodore N. Tsangaris, MD

From the Breast Cancer Program, Department of Oncology (VS, RS, DFH), Department of Pathology (CAE), Biostatistics Unit (RS), and Department of Surgery (MFP, TNT), Lombardi Cancer Center, Georgetown University School of Medicine, Washington, DC.

Correspondence: Address correspondence and reprint requests to: Vered Stearns, MD, University of Michigan Comprehensive Cancer Center, 6303 Cancer Center, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0942; Fax: 734-615-3942; E-mail: stearnsv{at}umich.edu

Background: After neoadjuvant chemotherapy, women with locally advanced breast cancer (LABC) undergo a modified radical mastectomy or lumpectomy with axillary lymph node dissection (ALND) and radiotherapy. Sentinel lymphadenectomy (SL) is accepted for axillary evaluation in early breast cancer. We assessed the feasibility and predictive value of SL after neoadjuvant chemotherapy.

Methods: Eligible women received neoadjuvant therapy for LABC and were scheduled to undergo a definitive surgical procedure. Vital blue dye SL was attempted followed by level I and II axillary dissection.

Results: SL was successful in 29 of 34 patients (detection rate, 85%). Thirteen patients (45%) had positive nodes, and eight (28%) had negative nodes on both SL and ALND. In five patients (17%), the sentinel node was the only positive node identified. Overall, there was a 90% concordance between SL and ALND. The false-negative rate and negative predictive value were 14% and 73%, respectively. Among the subgroup without inflammatory cancer, the detection and concordance rates were 89% and 96%, respectively. The false-negative rate was 6%, and the negative predictive value was 88%.

Conclusions: SL after neoadjuvant chemotherapy may reliably predict axillary staging except in inflammatory breast cancer. Further studies are required to assess the utility of SL as the only mode of axillary evaluation in these women.

Key Words: Locally advanced breast cancer • Inflammatory breast cancer • Neoadjuvant chemotherapy • Sentinel lymph node mapping • Sentinel lymphadenectomy




This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
K. E. Kilbride, M. C. Lee, A. V. Nees, V. M. Cimmino, K. M. Diehl, M. S. Sabel, D. F. Hayes, A. F. Schott, C. G. Kleer, A. E. Chang, et al.
Axillary Staging Prior to Neoadjuvant Chemotherapy for Breast Cancer: Predictors of Recurrence
Ann. Surg. Oncol., November 1, 2008; 15(11): 3252 - 3258.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
B. J. Grube, C. J. Christy, D. Black, M. Martel, L. Harris, J. Weidhaas, M. P. DiGiovanna, G. Chung, M. M. Abu-Khalaf, K. D. Miller, et al.
Breast Sentinel Lymph Node Dissection Before Preoperative Chemotherapy
Arch Surg, July 1, 2008; 143(7): 692 - 700.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
P. Gimbergues, C. Abrial, X. Durando, G. Le Bouedec, F. Cachin, F. Penault-Llorca, M. A. Mouret-Reynier, F. Kwiatkowski, J. Maublant, A. Tchirkov, et al.
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Is Accurate in Breast Cancer Patients with a Clinically Negative Axillary Nodal Status at Presentation
Ann. Surg. Oncol., May 1, 2008; 15(5): 1316 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff
Locally Advanced and Inflammatory Breast Cancer
J. Clin. Oncol., February 10, 2008; 26(5): 786 - 790.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. A. Newman, M. S. Sabel, A. V. Nees, A. Schott, K. M. Diehl, V. M. Cimmino, A. E. Chang, C. Kleer, D. F. Hayes, and L. A. Newman
Sentinel Lymph Node Biopsy Performed After Neoadjuvant Chemotherapy is Accurate in Patients with Documented Node-Positive Breast Cancer at Presentation
Ann. Surg. Oncol., October 1, 2007; 14(10): 2946 - 2952.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
L. Lelievre, G. Houvenaeghel, M. Buttarelli, I. Brenot-Rossi, L. Huiart, A. Tallet, C. Tarpin, and J. Jacquemier
Value of the Sentinel Lymph Node Procedure in Patients With Large Size Breast Cancer
Ann. Surg. Oncol., February 1, 2007; 14(2): 621 - 626.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J.-C. Yu, G.-C. Hsu, C.-B. Hsieh, C.-P. Yu, and T.-Y. Chao
Role of Sentinel Lymphadenectomy Combined with Intraoperative Ultrasound in the Assessment of Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy
Ann. Surg. Oncol., January 1, 2007; 14(1): 174 - 180.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
I. Sachelarie, M. L. Grossbard, M. Chadha, S. Feldman, M. Ghesani, and R. H. Blum
Primary Systemic Therapy of Breast Cancer
Oncologist, June 1, 2006; 11(6): 574 - 589.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Kaufmann, G. N. Hortobagyi, A. Goldhirsch, S. Scholl, A. Makris, P. Valagussa, J.-U. Blohmer, W. Eiermann, R. Jackesz, W. Jonat, et al.
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
J. Clin. Oncol., April 20, 2006; 24(12): 1940 - 1949.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. C. van Rijk, O. E. Nieweg, E. J. T. Rutgers, H. S. A. Oldenburg, R. V. Olmos, C. A. Hoefnagel, and B. B. R. Kroon
Sentinel Node Biopsy Before Neoadjuvant Chemotherapy Spares Breast Cancer Patients Axillary Lymph Node Dissection
Ann. Surg. Oncol., April 1, 2006; 13(4): 475 - 479.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. E. Cox, J. M. Cox, L. B. White, N. G. Stowell, J. D. Clark, N. Allred, M. Meyers, E. Dupont, B. Furman, and S. Minton
Sentinel Node Biopsy Before Neoadjuvant Chemotherapy for Determining Axillary Status and Treatment Prognosis in Locally Advanced Breast Cancer
Ann. Surg. Oncol., April 1, 2006; 13(4): 483 - 490.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. H. Lyman, A. E. Giuliano, M. R. Somerfield, A. B. Benson III, D. C. Bodurka, H. J. Burstein, A. J. Cochran, H. S. Cody III, S. B. Edge, S. Galper, et al.
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
J. Clin. Oncol., October 20, 2005; 23(30): 7703 - 7720.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. Khan, M. S. Sabel, A. Nees, K. M. Diehl, V. M. Cimmino, C. G. Kleer, A. F. Schott, D. F. Hayes, A. E. Chang, and L. A. Newman
Comprehensive Axillary Evaluation in Neoadjuvant Chemotherapy Patients With Ultrasonography and Sentinel Lymph Node Biopsy
Ann. Surg. Oncol., September 1, 2005; 12(9): 697 - 704.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. P. Mamounas, A. Brown, S. Anderson, R. Smith, T. Julian, B. Miller, H. D. Bear, C. B. Caldwell, A. P. Walker, W. M. Mikkelson, et al.
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
J. Clin. Oncol., April 20, 2005; 23(12): 2694 - 2702.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. Barranger, A. Cortez, D. Grahek, P. Callard, S. Uzan, and E. Darai
Laparoscopic Sentinel Node Procedure for Cervical Cancer: Impact of Neoadjuvant Chemoradiotherapy
Ann. Surg. Oncol., April 1, 2004; 11(4): 445 - 452.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. S. Cody III
Sentinel Lymph Node Biopsy for Breast Cancer: Does Anybody Not Need One?
Ann. Surg. Oncol., December 1, 2003; 10(10): 1131 - 1132.
[Full Text] [PDF]

Home page
 The OncologistHome page
S. H. Giordano
Update on Locally Advanced Breast Cancer
Oncologist, December 1, 2003; 8(6): 521 - 530.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
L. A. Newman, N. L. Pernick, V. Adsay, K. A. Carolin, P. I. Philip, S. Sipierski, D. L. Bouwman, M. A. Kosir, M. White, and D. W. Visscher
Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer Outcome
Ann. Surg. Oncol., August 1, 2003; 10(7): 734 - 739.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. E. Singletary, C. Allred, P. Ashley, L. W. Bassett, D. Berry, K. I. Bland, P. I. Borgen, G. Clark, S. B. Edge, D. F. Hayes, et al.
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
J. Clin. Oncol., September 1, 2002; 20(17): 3628 - 3636.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. I. Bland
Utilization of Sentinel Lymph Node Mapping to Determine Pathologic Outcomes for Patients Receiving Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
Ann. Surg. Oncol., April 1, 2002; 9(3): 217 - 219.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society of Surgical Oncology.